This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Douglas Sheridan
Global Program Leader at RallyBio


Doug has more than 20 years of R&D experience and is a co-inventor of six clinical drug candidates, including an orphan drug approved by the FDA in 2018. Doug recently joined Rallybio, a privately held, development-stage biotech focused on bringing life-transforming medicines to patients with devastating and rare disorders. Prior to Rallybio Doug served as Executive Director, Global Program Team Leader at Alexion Pharmaceuticals, leading the cross-functional development teams responsible for the strategy and execution to launch two global development programs. Doug earned his PhD in Neuroscience from Yale and B.S. in Biochemistry and Molecular Biology from Penn State.

Agenda Sessions

  • Design and Preclinical Characterization of ULTOMIRIS